Search Results - "Buerki, Robin A."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Immunotherapy of Primary Brain Tumors: Facts and Hopes by Buerki, Robin A, Chheda, Zinal S, Okada, Hideho

    Published in Clinical cancer research (01-11-2018)
    “…The field of cancer immunotherapy has made exciting progress for some cancer types in recent years. However, recent failures of late-phase clinical trials…”
    Get full text
    Journal Article
  2. 2

    An overview of meningiomas by Buerki, Robin A, Horbinski, Craig M, Kruser, Timothy, Horowitz, Peleg M, James, Charles David, Lukas, Rimas V

    Published in Future oncology (London, England) (01-09-2018)
    “…Meningiomas are the most common primary intracranial tumor. Important advances are occurring in meningioma research. These are expected to accelerate,…”
    Get full text
    Journal Article
  3. 3

    A Survey of the Neuro-Oncology Landscape by Lukas, Rimas V, Wu, Jing, Dey, Mahua, Buerki, Robin A, Byrne, Richard W, Dohrmann, George J

    “…The field of neuro-oncology is evolving rapidly. Many important advances have recently been reported, and other promising investigations have the potential to…”
    Get full text
    Journal Article
  4. 4

    The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection by Brown, Damien P, Jones, Des C, Anderson, Katie J, Lapaque, Nicolas, Buerki, Robin A, Trowsdale, John, Allen, Rachel L

    Published in BMC immunology (27-10-2009)
    “…Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with immunomodulatory functions. High-level expression of the receptors LILRB2…”
    Get full text
    Journal Article
  5. 5

    Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017 by Patil, Nirav, Kelly, Michael E, Yeboa, Debra Nana, Buerki, Robin A, Cioffi, Gino, Balaji, Sweta, Ostrom, Quinn T, Kruchko, Carol, Barnholtz-Sloan, Jill S

    Published in Neuro-oncology (Charlottesville, Va.) (01-06-2021)
    “…Abstract Background Limited population-based data exist for the brainstem gliomas for children ages ≤19 years, which includes high-grade aggressively growing…”
    Get full text
    Journal Article
  6. 6

    Stroke impact on mortality and psychologic morbidity within the Childhood Cancer Survivor Study by Mueller, Sabine, Kline, Cassie N., Buerki, Robin A., Chen, Yan, Yasui, Yutaka, Howell, Rebecca, Oeffinger, Kevin C., Leisenring, Wendy M., Robison, Leslie L., Armstrong, Gregory T., Fullerton, Heather J., Krull, Kevin R.

    Published in Cancer (01-03-2020)
    “…Background Poor socioeconomic and health‐related quality of life (HRQOL) outcomes in survivors of childhood cancer can lead to distress and overall negatively…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Building Team Medicine in the Management of CNS Metastases by Baskaran, Archit B, Buerki, Robin A, Khan, Osaama H, Gondi, Vinai, Stupp, Roger, Lukas, Rimas V, Villaflor, Victoria M

    Published in Journal of clinical medicine (07-06-2023)
    “…CNS metastases are often terminal for cancer patients and occur at an approximately 10-fold higher rate than primary CNS tumors. The incidence of these tumors…”
    Get full text
    Journal Article
  12. 12

    Case Report of Bone Marrow-Sparing Proton Therapy Craniospinal Irradiation for Central Nervous System Myelomatosis by Kauffmann, Greg, Buerki, Robin A, Lukas, Rimas V, Gondi, Vinai, Chmura, Steven J

    Published in Curēus (Palo Alto, CA) (28-11-2017)
    “…Central nervous system (CNS) involvement is rare but it is an increasingly recognized complication of the multiple myeloma. The craniospinal radiotherapy is a…”
    Get full text
    Journal Article
  13. 13

    Potentiation of acetylcholine action by huperzine-A and physostigmine on some vertebrate effectors, including human iris sphincter muscle by Patil, Kaustubha D, Buerki, Robin A, Patil, Popat N

    “…The main objective of this investigation was to compare the acetylcholine potentiating action of huperzine-A with acetylcholinesterase inhibitor physostigmine…”
    Get more information
    Journal Article
  14. 14

    The inhibitory receptor LILRB4 by Brown, Damien P, Jones, Des C, Anderson, Katie J, Lapaque, Nicolas, Buerki, Robin A, Trowsdale, John, Allen, Rachel L

    Published in BMC immunology (27-10-2009)
    “…Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with immunomodulatory functions. High-level expression of the receptors LILRB2…”
    Get full text
    Journal Article
  15. 15

    The inhibitory receptor LILRB4 , is upregulated in response to Salmonella infection by Brown, Damien P, Jones, Des C, Anderson, Katie J, Lapaque, Nicolas, Buerki, Robin A, Trowsdale, John, Allen, Rachel L

    Published in BMC immunology (27-10-2009)
    “…Background Leukocyte Ig-like receptors (LILR) are a family of innate immune receptors with immunomodulatory functions. High-level expression of the receptors…”
    Get full text
    Journal Article
  16. 16